Cardiotonic Agents

"Cardiotonic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).

Descriptor ID	D002316
MeSH Number(s)	D27.505.954.411.222 D27.720.799.080
Concept/Terms	Cardiotonic Agents Cardiotonic Agents Cardiac Stimulants Inotropic Agents, Positive Cardiac Cardiotonic Drugs Cardiotonics Myocardial Stimulants Cardioprotective Agents

Below are MeSH descriptors whose meaning is more general than "Cardiotonic Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Cardiotonic Agents [D27.505.954.411.222]
Specialty Uses of Chemicals [D27.720]
Protective Agents [D27.720.799]
Cardiotonic Agents [D27.720.799.080]

Below are MeSH descriptors whose meaning is more specific than "Cardiotonic Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cardiotonic Agents" by people in this website by year, and whether "Cardiotonic Agents" was a major or minor topic of these publications.

Bar chart showing 30 publications over 15 distinct years, with a maximum of 5 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2002	1	0	1
2004	3	2	5
2005	1	1	2
2006	1	1	2
2007	1	2	3
2008	0	2	2
2009	0	2	2
2010	2	1	3
2011	1	0	1
2012	1	1	2
2013	1	0	1
2014	2	0	2
2016	1	0	1
2017	0	2	2

Below are the most recent publications written about "Cardiotonic Agents" by people in Profiles.

Starling RC, Estep JD, Horstmanshof DA, Milano CA, Stehlik J, Shah KB, Bruckner BA, Lee S, Long JW, Selzman CH, Kasirajan V, Haas DC, Boyle AJ, Chuang J, Farrar DJ, Rogers JG. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results. JACC Heart Fail. 2017 Jul; 5(7):518-527.

View in: PubMed
Mysliwiec M, Bonita RE. Outpatient Emergencies: Acute Heart Failure. Med Clin North Am. 2017 May; 101(3):507-519.

View in: PubMed
McCurdy R, Jiang X, Clarkson TB, Nudy M, Schnatz PF. Vitamin D and conjugated equine estrogen: the association with coronary artery atherosclerosis in cynomolgus monkeys. Menopause. 2016 05; 23(5):481-7.

View in: PubMed
Rogers JG, Boyle AJ, O'Connell JB, Horstmanshof DA, Haas DC, Slaughter MS, Park SJ, Farrar DJ, Starling RC. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: design and rationale of the ROADMAP clinical trial. Am Heart J. 2015 Feb; 169(2):205-210.e20.

View in: PubMed
Rajapreyar IN, Ennezat PV, Le Jemtel TH. Toward safe inotropic therapy. J Cardiovasc Pharmacol. 2014 Oct; 64(4):385-92.

View in: PubMed
Wang Y, Li X, Wang X, Lau W, Wang Y, Xing Y, Zhang X, Ma X, Gao F. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3ß signaling and inhibition of the mitochondria-dependent apoptotic pathway. PLoS One. 2013; 8(8):e70956.

View in: PubMed
Perman SM, Goyal M, Gaieski DF. Initial emergency department diagnosis and management of adult patients with severe sepsis and septic shock. Scand J Trauma Resusc Emerg Med. 2012; 20:41.

View in: PubMed
Yi W, Sun Y, Yuan Y, Lau WB, Zheng Q, Wang X, Wang Y, Shang X, Gao E, Koch WJ, Ma XL. C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart. Circulation. 2012 Jun 26; 125(25):3159-69.

View in: PubMed
Yi W, Sun Y, Gao E, Wei X, Lau WB, Zheng Q, Wang Y, Yuan Y, Wang X, Tao L, Li R, Koch W, Ma XL. Reduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms. Antioxid Redox Signal. 2011 Oct 1; 15(7):1779-88.

View in: PubMed
Wang J, Gao E, Rabinowitz J, Song J, Zhang XQ, Koch WJ, Tucker AL, Chan TO, Feldman AM, Cheung JY. Regulation of in vivo cardiac contractility by phospholemman: role of Na+/Ca2+ exchange. Am J Physiol Heart Circ Physiol. 2011 Mar; 300(3):H859-68.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement